Key Takeaways
- Rocket Lab shares climbed approximately 7% following Cantor Fitzgerald’s reiterated Buy stance on the stock
- The company’s addition to the Nasdaq-100 on June 22 is viewed as a major driver for institutional demand
- KeyBanc initiated coverage with an Overweight rating and $135 target price, projecting over 30% gains
- Analysts attribute recent price weakness to portfolio rebalancing after SpaceX’s public debut rather than operational issues
- Consensus among Wall Street analysts remains Strong Buy with a mean target of $108.70 and upper-end estimate of $150
Rocket Lab (RKLB) shares climbed approximately 7% during Monday’s trading session following supportive commentary from two prominent Wall Street firms. Cantor Fitzgerald maintained its positive outlook on the aerospace company, while KeyBanc delivered a new bullish call — providing support for a stock that had retreated 11% just days earlier on June 12.
Shares of RKLB have declined roughly 27% from the peak levels reached in late May.
Cantor Fitzgerald’s Andres Sheppard emphasized the significance of June 22, when Rocket Lab becomes an official constituent of the Nasdaq-100 Index. This milestone elevates the company’s visibility among institutional portfolios and mandates purchases from index-tracking funds and exchange-traded products.
Sheppard characterized RKLB’s entry into the Nasdaq-100 as a “material” development — a characterization that appears well-founded given the calendar proximity.
Looking past the index event, Sheppard identified several competitive advantages that provide Rocket Lab with structural defensibility against emerging rivals. These factors include an established launch history, a diversified vehicle portfolio featuring Electron, HASTE, and the forthcoming Neutron rocket, a balanced customer base spanning commercial and government sectors, and operational launch facilities across New Zealand and the United States.
Sheppard holds a ranking of 1,456 among more than 12,200 analysts monitored by TipRanks, maintaining a perfect 100% accuracy rate on RKLB predictions with an average one-year gain of 196.92% per recommendation.
KeyBanc Advocates for Accumulation During Weakness
Michael Leshock of KeyBanc elevated RKLB to Overweight status while establishing a $135 valuation target — suggesting potential appreciation exceeding 30% from recent closing prices. His investment rationale emphasizes that the stock’s recent decline stems primarily from market dynamics rather than deteriorating business fundamentals.
Following SpaceX‘s landmark public market entry on the Nasdaq exchange, institutional capital managers rushed to establish positions in the newly accessible space leader. This activity necessitated liquidation of existing aerospace positions — Rocket Lab among them. Leshock described the selloff as capital reallocation rather than a reflection of weakening company prospects.
He identified a persistent structural imbalance in global launch capacity that should maintain supply constraints for more than ten years. Accelerating satellite constellation deployments and expanding military investment in orbital infrastructure compound this supply-demand mismatch.
Rocket Lab concluded its first quarter holding a contract pipeline worth more than $2.2 billion. The firm is also competing for significant opportunities including NASA’s Mars Telecommunications Orbiter initiative.
End-to-End Control as Sustainable Advantage
Leshock underscored Rocket Lab’s vertically integrated operational model as a crucial competitive differentiator. With approximately 90 successful Electron launches completed and increasing program details emerging around the Neutron medium-class vehicle, he noted the company demonstrates “institutional-grade” operational capability.
He believes RKLB is building resilience against the conventional risks facing small-launch operators by controlling a larger portion of its value chain — an approach that echoes SpaceX’s proven strategic blueprint.
The investment community widely recognizes Rocket Lab as the definitive runner-up to SpaceX in the commercial launch sector.
Wall Street’s aggregate view on RKLB stands at Strong Buy, derived from 10 Buy recommendations and three Hold ratings. The consensus valuation target rests at $108.70, while the most optimistic projection reaches $150 — indicating approximately 37% appreciation potential from present trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
